|
COMMERCE BUSINESS DAILY ISSUE OF NOVEMBER 20,1997 PSA#1976Director, USAMRAA, 820 Chandler St, Fort Detrick, MD 21702-5014 A -- GULF WAR ILLNESS RESEARCH PROGRAM SOL CBD&&&-9711-0001 POC CRAIG
D. LEBO, Contracting Officer 301-619-2036 E-MAIL: Click here to
contact the Contracting Officer via e-mail.,
craig_lebo@ftdetrck-ccmail.army.mil. GULF WAR ILLNESSES RESEARCH
PROGRAM -- The USAMRMC announces an FY 98 competition for the Gulf War
Illnesses Research Program. The Department of Defense solicits
research proposals for studies on the possible health risks associated
with service in the Gulf War. The goals of this research are to
discover the pathogenesis of unexplained illnesses of Gulf War
veterans, to use this understanding of basic mechanisms to help
veterans, and to avoid or reduce the occurrence of such unexplained
illnesses in future military deployments. Proposals may be submitted
only by U.S. institutions of higher education (other than federal
government) with degree-granting programs in science and/or engineering
(~universities~), or by consortia led by such institutions. This
solicitation is specifically for research in three areas of focus: (1)
Investigation of the confluence of cognitive, emotional and physical
factors which produce chronic, non- specific symptoms and physiological
outcomes typical of the undiagnosed illnesses of some Gulf War
veterans. Examples of studies sought range from sociological studies of
the stress manifestations of military deployment to basic studies of
psychoneuroimmunological mechanisms which elucidate physical symptoms
such as muscle weakness, fatigue, and joint pain; (2) Studies of
toxicity and toxic interactions of environmental chemicals,
prophylactic drugs, and military materiel. Examples of studies sought
in this topic include, but are not limited to, improved understanding
of health effects of combinations of exposures specific to the Gulf War
(including jet fuel vapor, pesticides and insect repellents, and
pyridostigmine bromide), studies of biomarkers to denote individual
exposure to toxic substances, and the development of near-real time
bioassays and bioelectronic sensor technologies for assessment of
toxicological hazards in future deployments. This latter research
should emphasize identification of fundamental physiological endpoints
in bioassays which could be applied to bioelectronic sensor
development to identify hazards from unidentified chemicals and
chemical mixtures; (3) Studies of long-term health consequences
associated with exposure to subclinical levels of chemical warfare
agents. Examples include epidemiological studies of soldiers who may
have been exposed to chemical warfare agent without acute symptoms, and
epidemiological studies on the health consequences of exposure in
populations, such as passengers present during the Tokyo subway attack
and individuals who participated in chemical agent research or worked
in production plants or storage facilities. Full proposals must be
prepared in accordance with USAMRMC Broad Agency Announcement 95-1.
This is accessible on the Internet at http://www- usamraa.army.mil.
USAMRMC will issue no other version of this program description; no
paper copy will be available from USAMRMC. No preproposals are
necessary, all are encouraged to submit if the proposal content
addresses any of the three studies above. Proposals typically average
2-4 years in duration and typically range in cost between $200K and
$1.5M. Funds available for this solicitation total approximately $8M.
Full proposals are due to Commander, U.S. Army Medical Research and
Materiel Command, ATTN: MCMR-AAA (GWI), Fort Detrick, MD 21702-5014, by
4:00 p.m. EST on 4 February 1998. The primary evaluation criteria will
be (1) scientific and technical merits of the proposed research as
determined by external (non-DOD) peer review, and (2) relevance and
potential contributions of the research to Gulf War illnesses as
determined by the Research Working Group of the Persian Gulf Veterans'
Coordinating Board. Collaboration with DOD laboratories and other
organizations involved in medical research for defense applications is
encouraged but not required. (0322) Loren Data Corp. http://www.ld.com (SYN# 0003 19971120\A-0003.SOL)
A - Research and Development Index Page
|
|